Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-Cell lymphoma

Journal of Investigative Dermatology

Volumn 130, Issue 9, 2010, Pages 2304-2311

  Miyagaki, Tomomitsu ^a   Sugaya, Makoto ^a   Fujita, Hideki ^a   Ohmatsu, Hanako ^a   Kakinuma, Takashi ^a   Kadono, Takafumi ^a   Tamaki, Kunihiko ^a   Sato, Shinichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR3; EOTAXIN 3; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TH2 CELL;

EID: 77955708979     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.128     Document Type: Article

References (37)

1. Asano Y, Ihn H, Yamane K et al. (2004) Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. J Clin Invest 113:253-264
2. Baraniuk JN (1997) Pathogenesis of allergic rhinitis. J Allergy Clin Immunol 99:S763-72
3. Beaulieu S, Robbiani DF, Du X et al. (2002) Expression of a functional eotaxin (CC chemokine ligand 11) receptor CCR3 by human dendritic cells. J Immunol 169:2925-2936
4. Berkman N, Ohnona S, Chung FK et al. (2001) Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24hours after allergen challenge. Am J Respir Cell Mol Biol 24:682-687
5. Campbell EM, Kunkel SL, Strieter RM et al. (1998) Temporal role of chemokines in a murine model of cockroach allergen-induced airway hyperreactivity and eosinophilia. J Immunol 161:7047-7053
6. Chong BF, Wilson AJ, Gibson HM et al. (2008) Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma/mycosis fungoides. Clin Cancer Res 14:646-653
7. Dummer R, Heald PW, Nestle FO et al. (1996) Sézary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). Blood 88:1383-1389
8. Echchakir H, Bagot M, Dorothée G et al. (2000) Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis. J Invest Dermatol 115:74-80
9. Forssmann U, Uguccioni M, Loetscher P et al. (1997) Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J Exp Med 185:2171-2176
10. Ganzalo JA, Jia GQ, Aguirre V et al. (1996) Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity 4:1-14
11. Hoeck J, Woisetschläger M (2001) Activation of eotaxin-3/CCLl26 gene expression in human dermal fibroblasts is mediated by STAT6. J Immunol 167:3216-3222
12. Jundt F, Anagnostopoulos I, Bommert K et al. (1999) Hodgkin/Reed- Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils. Blood 94:2065-2071
13. Kaburagi Y, Shimada Y, Nagaoka T et al. (2001) Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis. Arch Dermatol Res 293:350-355
14. Kagami S, Kakinuma T, Saeki H et al. (2003) Significant elevation of serum levels of eotaxin-3, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3 levels reflect the disease activity of atopic dermatitis. Clin Exp Immunol 134:309-313
15. Kagami S, Saeki H, Komine M et al. (2005) Interleukin-4 and interleukin-13 enhance eotaxin-3 production in a human keratinocyte cell line, HaCaT cells. Clin Exp Immunol 141:459-466
16. Kagami S, Sugaya M, Minatani Y et al. (2006) Elevated serum CTACK levels in CTCL. J Invest Dermatol 126:1189-1191
17. Kakinuma T, Sugaya M, Nakamura K et al. (2003) Thymus and activation-regulated chemokine (TARC) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol 48:23-30
18. Kallinich T, Muche JM, Qin S et al. (2003) Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides. J Invest Dermatol 121:1045-1052
19. Kaplan EH, Rosen ST, Norris DB et al. (1990) Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma. J Natl Cancer Inst 82:208-212
20. Kleinhans M, Tun-Kyi A, Gilliet M et al. (2003) Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma. Blood 101:1487-1493
21. Mart́i RM, Estrach T, Reverter JC et al. (1991) Prognostic clinicopathologic factors in cutaneous T-cell lymphoma. Arch Dermatol 127:1511-1516
22. Miyamasu M, Nakajima T, Misaki Y et al. (1999) Dermal fibroblasts represent a potent major source of human eotaxin: in vitro production and cytokine-mediated regulation. Cytokine 11:751-758
23. Nishi N, Yamamoto S, Ou W et al. (2008) Enhanced eotaxin-3 production by IL-4 through IFN-gamma-induced upregulation of type 1 IL-4 receptor in keratinocytes. Biochem Biophys Res Commun 376:234-240
24. Papadavid E, Economidou J, Psarra A et al. (2003) The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome. Br J Dermatol 148:709-718
25. Rothenberg ME, Luster AD, Leder P (1995) Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc Natl Acad Sci USA 92:8960-8964
26. Sallusto F, Mackay CR, Lanzavecchia A (1997) Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277:2005-2007
27. Shinkai A, Yoshisue H, Koike M et al. (1999) A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J Immunol 163:1602-1610
28. Sugaya M, Fang L, Cardones AR et al. (2006) Oncostatin M enhances CCL21 expression by microvascular endothelial cells and increases the efficiency of dendritic cell trafficking to lymph nodes. J Immunol 177:7665-7672
29. Teruya-Feldstein J, Jaffe ES, Burd PR et al. (1999) Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia. Blood 93:2463-2470
30. Uguccioni M, Mackay CR, Ochensberger B et al. (1997) High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest 100:1137-1143
31. Urosevic M, Fujii K, Calmels B et al. (2007) Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomas. J Clin Invest 117:2834-2846
32. Vowels BR, Lessin SR, Cassin M et al. (1994) Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol 103:669-673
33. Wasik MA, Vonderheid EC, Bigler RD et al. (1996) Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications. Arch Dermatol 132:42-47
34. Willemze R, Jaffe ES, Burg G et al. (2005) WHO-EORTC classification for cutaneous lymphomas. Blood 105:3768-3785
35. Yagi H, Seo N, Ohshima A et al. (2006) Chemokine receptor expression in cutaneous T cell and NK/T-cell lymphomas: immunohistochemical staining and in vitro chemotactic assay. Am J Surg Pathol 30:1111-1119
36. Yawalkar N, Uguccioni M, Schärer J et al. (1999) Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 113:43-48
37. Zachariae C, Larsen CS, Kaltoft K et al. (1991) Soluble IL2 receptor serum levels and epidermal cytokines in mycosis fungoides and related disorders. Acta Dermatol Venereol 71:465-470